Skip to main content

Table 5 Comparison of present series to prospective preoperative chemoradiotherapy trials in gastric cancer

From: Preoperative chemoradiotherapy for locally advanced gastric cancer

Series

Patients (n)

R0 resection (%)*

pCR rate (%)*

Overall survival (%)**

M.D. Anderson (Lowy et al.)

24

95

11

N/A

Multi-institutional (Ajani et al.)

33

82

36

54 (2)

M.D. Anderson(Ajani et al.)

41

80

20

N/A

RTOG 9904 (Ajani et al.)

43

75

31

72 (1)

Current series (Pepek et al.)

48

86

19

40 (3)

  1. * Percentages are based on number of patients who underwent surgery after preoperative chemoradiotherapy.
  2. ** Numbers in parentheses are actuarial data in years.